Frequencies for first 10,000 rows of indi_pt variable in indi2007q3 dataset : 'Preferred Term'-level medical | terminology describing the Indication | for use | Freq. Percent Cum. ----------------------------------------+----------------------------------- ABDOMINAL ABSCESS | 1 0.01 0.01 ABDOMINAL DISCOMFORT | 2 0.02 0.03 ABDOMINAL DISTENSION | 1 0.01 0.04 ABDOMINAL INFECTION | 1 0.01 0.05 ABDOMINAL MASS | 1 0.01 0.06 ABDOMINAL PAIN | 5 0.05 0.11 ABDOMINAL PAIN UPPER | 8 0.08 0.19 ABNORMAL BEHAVIOUR | 4 0.04 0.23 ABNORMAL FAECES | 1 0.01 0.24 ABORTION INDUCED | 3 0.03 0.27 ABSCESS | 2 0.02 0.29 ACARODERMATITIS | 1 0.01 0.30 ACCIDENTAL EXPOSURE | 8 0.08 0.38 ACNE | 32 0.32 0.70 ACNE CYSTIC | 2 0.02 0.72 ACNE PUSTULAR | 1 0.01 0.73 ACQUIRED IMMUNODEFICIENCY SYNDROME | 21 0.21 0.94 ACROMEGALY | 2 0.02 0.96 ACUTE CORONARY SYNDROME | 7 0.07 1.03 ACUTE ENDOCARDITIS | 2 0.02 1.05 ACUTE LEUKAEMIA | 1 0.01 1.06 ACUTE LYMPHOCYTIC LEUKAEMIA | 46 0.46 1.52 ACUTE MYELOID LEUKAEMIA | 23 0.23 1.75 ACUTE MYELOID LEUKAEMIA RECURRENT | 8 0.08 1.83 ACUTE MYOCARDIAL INFARCTION | 16 0.16 1.99 ACUTE PULMONARY OEDEMA | 1 0.01 2.00 ACUTE TONSILLITIS | 2 0.02 2.02 ADDISON'S DISEASE | 5 0.05 2.07 ADENOCARCINOMA | 3 0.03 2.10 ADENOCARCINOMA PANCREAS | 3 0.03 2.13 ADENOMA BENIGN | 1 0.01 2.14 ADJUSTMENT DISORDER | 1 0.01 2.15 ADRENAL INSUFFICIENCY | 1 0.01 2.16 ADRENOCORTICAL CARCINOMA | 2 0.02 2.18 AFFECTIVE DISORDER | 3 0.03 2.21 AGGRESSION | 3 0.03 2.24 AGITATION | 3 0.03 2.27 AKATHISIA | 2 0.02 2.29 ALANINE AMINOTRANSFERASE INCREASED | 1 0.01 2.30 ALCOHOLISM | 4 0.04 2.34 ALLERGY PROPHYLAXIS | 2 0.02 2.36 ALOPECIA | 1 0.01 2.37 AMAUROSIS FUGAX | 1 0.01 2.38 AMENORRHOEA | 2 0.02 2.40 AMYLOIDOSIS | 2 0.02 2.42 ANAEMIA | 11 0.11 2.53 ANAEMIA HAEMOLYTIC AUTOIMMUNE | 1 0.01 2.54 ANAEMIA OF MALIGNANT DISEASE | 8 0.08 2.62 ANAESTHESIA | 11 0.11 2.73 ANAL STENOSIS | 1 0.01 2.74 ANALGESIA | 6 0.06 2.80 ANALGESIC THERAPY | 3 0.03 2.83 ANAPHYLACTIC SHOCK | 1 0.01 2.84 ANASTOMOTIC ULCER HAEMORRHAGE | 1 0.01 2.85 ANGINA PECTORIS | 21 0.21 3.06 ANGIOGRAM | 3 0.03 3.09 ANGIOGRAM CEREBRAL | 1 0.01 3.10 ANGIOPLASTY | 2 0.02 3.12 ANKYLOSING SPONDYLITIS | 23 0.23 3.35 ANOREXIA | 2 0.02 3.37 ANOVULATORY CYCLE | 1 0.01 3.38 ANOXIA | 1 0.01 3.39 ANTI-NEUTROPHIL CYTOPLASMIC ANTIBODY .. | 2 0.02 3.41 ANTIBIOTIC LEVEL | 1 0.01 3.42 ANTIBIOTIC PROPHYLAXIS | 7 0.07 3.49 ANTICOAGULANT THERAPY | 8 0.08 3.57 ANTICONVULSANT DRUG LEVEL | 2 0.02 3.59 ANTIDEPRESSANT THERAPY | 6 0.06 3.65 ANTIEMETIC SUPPORTIVE CARE | 20 0.20 3.85 ANTIFUNGAL PROPHYLAXIS | 6 0.06 3.91 ANTIINFLAMMATORY THERAPY | 1 0.01 3.92 ANTIPHOSPHOLIPID SYNDROME | 2 0.02 3.94 ANTIPLATELET THERAPY | 15 0.15 4.09 ANTIVIRAL PROPHYLAXIS | 7 0.07 4.16 ANXIETY | 65 0.65 4.81 ANXIETY DISORDER | 5 0.05 4.86 ANXIOLYTIC THERAPY | 1 0.01 4.87 AORTIC ARTERIOSCLEROSIS | 1 0.01 4.88 AORTIC VALVE REPLACEMENT | 1 0.01 4.89 APLASTIC ANAEMIA | 2 0.02 4.91 ARRHYTHMIA | 12 0.12 5.03 ARTERIAL OCCLUSIVE DISEASE | 1 0.01 5.04 ARTERIAL STENOSIS | 1 0.01 5.05 ARTERIOGRAM CORONARY | 1 0.01 5.06 ARTERIOSCLEROSIS CORONARY ARTERY | 1 0.01 5.07 ARTERIOSCLEROSIS OBLITERANS | 2 0.02 5.09 ARTERITIS | 2 0.02 5.11 ARTHRALGIA | 20 0.20 5.31 ARTHRITIS | 29 0.29 5.60 ARTHROPATHY | 6 0.06 5.66 ASBESTOSIS | 1 0.01 5.67 ASCITES | 4 0.04 5.71 ASPERGILLOSIS | 1 0.01 5.72 ASTHENIA | 1 0.01 5.73 ASTHMA | 100 1.00 6.73 ASTHMA EXERCISE INDUCED | 1 0.01 6.74 ATRIAL FIBRILLATION | 54 0.54 7.28 ATRIAL FLUTTER | 2 0.02 7.30 ATROPHIC VULVOVAGINITIS | 1 0.01 7.31 ATTENTION DEFICIT/HYPERACTIVITY DISOR.. | 29 0.29 7.60 ATYPICAL MYCOBACTERIAL INFECTION | 2 0.02 7.62 B-CELL LYMPHOMA | 30 0.30 7.92 BACK DISORDER | 2 0.02 7.94 BACK INJURY | 1 0.01 7.95 BACK PAIN | 42 0.42 8.37 BACTERAEMIA | 4 0.04 8.41 BACTERIAL INFECTION | 1 0.01 8.42 BARRETT'S OESOPHAGUS | 1 0.01 8.43 BASEDOW'S DISEASE | 1 0.01 8.44 BEHCET'S SYNDROME | 3 0.03 8.47 BENIGN PROSTATIC HYPERPLASIA | 13 0.13 8.60 BILE DUCT CANCER | 3 0.03 8.63 BILE DUCT CANCER RECURRENT | 1 0.01 8.64 BILE OUTPUT | 1 0.01 8.65 BIPOLAR DISORDER | 56 0.56 9.21 BIPOLAR I DISORDER | 16 0.16 9.37 BIPOLAR II DISORDER | 1 0.01 9.38 BLADDER CANCER | 2 0.02 9.40 BLADDER DISORDER | 2 0.02 9.42 BLADDER SPASM | 1 0.01 9.43 BLADDER TRANSITIONAL CELL CARCINOMA | 1 0.01 9.44 BLEPHAROSPASM | 1 0.01 9.45 BLOOD CHOLESTEROL | 19 0.19 9.64 BLOOD CHOLESTEROL ABNORMAL | 2 0.02 9.66 BLOOD CHOLESTEROL DECREASED | 1 0.01 9.67 BLOOD CHOLESTEROL INCREASED | 25 0.25 9.92 BLOOD GLUCOSE | 4 0.04 9.96 BLOOD GLUCOSE INCREASED | 3 0.03 9.99 BLOOD IRON DECREASED | 1 0.01 10.00 BLOOD IRON INCREASED | 3 0.03 10.03 BLOOD MAGNESIUM DECREASED | 1 0.01 10.04 BLOOD POTASSIUM | 1 0.01 10.05 BLOOD POTASSIUM DECREASED | 1 0.01 10.06 BLOOD PRESSURE | 17 0.17 10.23 BLOOD PRESSURE DECREASED | 1 0.01 10.24 BLOOD PRESSURE INCREASED | 16 0.16 10.40 BLOOD PRESSURE MANAGEMENT | 1 0.01 10.41 BLOOD PROLACTIN ABNORMAL | 1 0.01 10.42 BLOOD TESTOSTERONE DECREASED | 1 0.01 10.43 BLOOD TRIGLYCERIDES INCREASED | 8 0.08 10.51 BONE CANCER METASTATIC | 2 0.02 10.53 BONE DENSITY DECREASED | 2 0.02 10.55 BONE DISORDER | 6 0.06 10.61 BONE LESION | 1 0.01 10.62 BONE MARROW CONDITIONING REGIMEN | 8 0.08 10.70 BONE MARROW TRANSPLANT | 2 0.02 10.72 BONE NEOPLASM MALIGNANT | 1 0.01 10.73 BONE PAIN | 2 0.02 10.75 BONE SARCOMA | 1 0.01 10.76 BONE SCAN | 1 0.01 10.77 BORDERLINE PERSONALITY DISORDER | 1 0.01 10.78 BRAIN ABSCESS | 1 0.01 10.79 BRAIN OEDEMA | 3 0.03 10.82 BREAKTHROUGH PAIN | 7 0.07 10.89 BREAST CANCER | 405 4.05 14.94 BREAST CANCER FEMALE | 8 0.08 15.02 BREAST CANCER METASTATIC | 19 0.19 15.21 BREAST CANCER STAGE I | 1 0.01 15.22 BREAST CELLULITIS | 1 0.01 15.23 BREAST NEOPLASM | 1 0.01 15.24 BRIEF PSYCHOTIC DISORDER WITH MARKED .. | 2 0.02 15.26 BRONCHIECTASIS | 4 0.04 15.30 BRONCHITIS | 14 0.14 15.44 BRONCHITIS CHRONIC | 5 0.05 15.49 BRONCHOPNEUMONIA | 5 0.05 15.54 BRONCHOPULMONARY ASPERGILLOSIS | 2 0.02 15.56 BRONCHOSPASM | 2 0.02 15.58 BURNING SENSATION | 3 0.03 15.61 CACHEXIA | 1 0.01 15.62 CANCER PAIN | 18 0.18 15.80 CANDIDA PNEUMONIA | 1 0.01 15.81 CANDIDIASIS | 6 0.06 15.87 CARCINOMA IN SITU OF BLADDER | 1 0.01 15.88 CARDIAC DISORDER | 4 0.04 15.92 CARDIAC FAILURE | 27 0.27 16.19 CARDIAC FAILURE CHRONIC | 6 0.06 16.25 CARDIAC FAILURE CONGESTIVE | 4 0.04 16.29 CARDIAC NEOPLASM MALIGNANT | 1 0.01 16.30 CARDIAC OPERATION | 2 0.02 16.32 CARDIAC PHARMACOLOGIC STRESS TEST | 1 0.01 16.33 CARDIAC STRESS TEST | 2 0.02 16.35 CARDIOMYOPATHY | 2 0.02 16.37 CARDIOVASCULAR DISORDER | 5 0.05 16.42 CARDIOVASCULAR EVENT PROPHYLAXIS | 8 0.08 16.50 CARDIOVERSION | 1 0.01 16.51 CARPAL TUNNEL SYNDROME | 1 0.01 16.52 CATAPLEXY | 1 0.01 16.53 CATARACT | 1 0.01 16.54 CATARACT OPERATION | 1 0.01 16.55 CATHETERISATION CARDIAC | 1 0.01 16.56 CELLULITIS | 2 0.02 16.58 CEREBRAL ARTERY EMBOLISM | 1 0.01 16.59 CEREBRAL HAEMORRHAGE | 4 0.04 16.63 CEREBRAL INFARCTION | 13 0.13 16.76 CEREBRAL ISCHAEMIA | 1 0.01 16.77 CEREBRAL TOXOPLASMOSIS | 4 0.04 16.81 CEREBROVASCULAR ACCIDENT | 2 0.02 16.83 CEREBROVASCULAR ACCIDENT PROPHYLAXIS | 9 0.09 16.92 CEREBROVASCULAR DISORDER | 2 0.02 16.94 CERVIX CANCER METASTATIC | 1 0.01 16.95 CERVIX CARCINOMA | 1 0.01 16.96 CHELATION THERAPY | 1 0.01 16.97 CHEMICAL POISONING | 1 0.01 16.98 CHEMOTHERAPY | 33 0.33 17.31 CHEST DISCOMFORT | 2 0.02 17.33 CHEST PAIN | 21 0.21 17.54 CHOLANGITIS | 2 0.02 17.56 CHOLECYSTECTOMY | 2 0.02 17.58 CHONDRITIS | 2 0.02 17.60 CHONDROPATHY | 4 0.04 17.64 CHORIOCARCINOMA | 1 0.01 17.65 CHOROID PLEXUS CARCINOMA | 6 0.06 17.71 CHOROIDAL DETACHMENT | 1 0.01 17.72 CHRONIC INFLAMMATORY DEMYELINATING PO.. | 1 0.01 17.73 CHRONIC LYMPHOCYTIC LEUKAEMIA | 27 0.27 18.00 CHRONIC MYELOID LEUKAEMIA | 13 0.13 18.13 CHRONIC OBSTRUCTIVE PULMONARY DISEASE | 28 0.28 18.41 CHRONIC SINUSITIS | 2 0.02 18.43 CIRCADIAN RHYTHM SLEEP DISORDER | 1 0.01 18.44 CLEAR CELL CARCINOMA OF THE KIDNEY | 1 0.01 18.45 COAGULOPATHY | 1 0.01 18.46 COELIAC DISEASE | 1 0.01 18.47 COGNITIVE DISORDER | 1 0.01 18.48 COLITIS | 5 0.05 18.53 COLITIS ULCERATIVE | 68 0.68 19.21 COLLAGEN DISORDER | 1 0.01 19.22 COLON CANCER | 17 0.17 19.39 COLON CANCER METASTATIC | 5 0.05 19.44 COLONOSCOPY | 1 0.01 19.45 COLONY STIMULATING FACTOR THERAPY | 3 0.03 19.48 COLORECTAL CANCER | 21 0.21 19.69 COLORECTAL CANCER METASTATIC | 24 0.24 19.93 COMA | 2 0.02 19.95 COMPLEX PARTIAL SEIZURES | 1 0.01 19.96 COMPLEX REGIONAL PAIN SYNDROME | 2 0.02 19.98 COMPLICATION OF PREGNANCY | 1 0.01 19.99 COMPUTERISED TOMOGRAM | 2 0.02 20.01 CONDUCT DISORDER | 1 0.01 20.02 CONGESTIVE CARDIOMYOPATHY | 1 0.01 20.03 CONJUNCTIVITIS | 1 0.01 20.04 CONSTIPATION | 68 0.68 20.72 CONTRACEPTION | 36 0.36 21.08 CONVULSION | 42 0.42 21.50 CONVULSION PROPHYLAXIS | 6 0.06 21.56 CORD BLOOD TRANSPLANT THERAPY | 29 0.29 21.85 CORONARY ANGIOPLASTY | 5 0.05 21.90 CORONARY ARTERY BYPASS | 2 0.02 21.92 CORONARY ARTERY DISEASE | 9 0.09 22.01 COUGH | 15 0.15 22.16 CRANIAL NEUROPATHY | 1 0.01 22.17 CRANIOPHARYNGIOMA | 1 0.01 22.18 CROHN'S DISEASE | 87 0.87 23.05 CYSTINOSIS | 1 0.01 23.06 CYSTITIS | 5 0.05 23.11 CYSTITIS INTERSTITIAL | 1 0.01 23.12 CYSTOCELE | 1 0.01 23.13 CYSTOSTOMY | 3 0.03 23.16 CYTOMEGALOVIRUS COLITIS | 1 0.01 23.17 CYTOMEGALOVIRUS INFECTION | 2 0.02 23.19 CYTOMEGALOVIRUS OESOPHAGITIS | 2 0.02 23.21 CYTOMEGALOVIRUS VIRAEMIA | 1 0.01 23.22 DECREASED APPETITE | 1 0.01 23.23 DEEP VEIN THROMBOSIS | 11 0.11 23.34 DEHYDRATION | 6 0.06 23.40 DELIRIUM | 6 0.06 23.46 DELUSION | 1 0.01 23.47 DEMENTIA | 15 0.15 23.62 DEMENTIA ALZHEIMER'S TYPE | 11 0.11 23.73 DENTAL CARE | 2 0.02 23.75 DENTAL CLEANING | 1 0.01 23.76 DENTAL DISORDER PROPHYLAXIS | 3 0.03 23.79 DEPRESSED MOOD | 1 0.01 23.80 DEPRESSION | 209 2.09 25.89 DEPRESSION SUICIDAL | 1 0.01 25.90 DEPRESSIVE SYMPTOM | 4 0.04 25.94 DERMATITIS | 3 0.03 25.97 DERMATITIS ATOPIC | 2 0.02 25.99 DERMATOSIS | 1 0.01 26.00 DIABETES INSIPIDUS | 1 0.01 26.01 DIABETES MELLITUS | 178 1.78 27.79 DIABETES PROPHYLAXIS | 1 0.01 27.80 DIABETIC FOOT INFECTION | 1 0.01 27.81 DIABETIC NEUROPATHY | 7 0.07 27.88 DIABETIC RETINAL OEDEMA | 1 0.01 27.89 DIABETIC VASCULAR DISORDER | 1 0.01 27.90 DIAGNOSTIC PROCEDURE | 2 0.02 27.92 DIALYSIS | 14 0.14 28.06 DIARRHOEA | 13 0.13 28.19 DIFFUSE LARGE B-CELL LYMPHOMA | 4 0.04 28.23 DISSEMINATED INTRAVASCULAR COAGULATION | 3 0.03 28.26 DISSEMINATED TUBERCULOSIS | 2 0.02 28.28 DISSOCIATIVE DISORDER | 1 0.01 28.29 DISTURBANCE IN ATTENTION | 2 0.02 28.31 DIURETIC THERAPY | 5 0.05 28.36 DIVERTICULITIS | 1 0.01 28.37 DIZZINESS | 4 0.04 28.41 DRUG ABUSER | 1 0.01 28.42 DRUG DEPENDENCE | 5 0.05 28.47 DRUG EXPOSURE DURING PREGNANCY | 31 0.31 28.78 DRUG HYPERSENSITIVITY | 2 0.02 28.80 DRUG INTERACTION POTENTIATION | 1 0.01 28.81 DRUG LEVEL | 2 0.02 28.83 DRUG THERAPY | 1 0.01 28.84 DRUG TOXICITY | 1 0.01 28.85 DRUG TOXICITY PROPHYLAXIS | 1 0.01 28.86 DRUG USE FOR UNKNOWN INDICATION | 1,465 14.65 43.51 DRUG WITHDRAWAL MAINTENANCE THERAPY | 2 0.02 43.53 DRUG WITHDRAWAL SYNDROME | 2 0.02 43.55 DRY EYE | 3 0.03 43.58 DRY MOUTH | 3 0.03 43.61 DUODENAL ULCER | 1 0.01 43.62 DYSAESTHESIA | 1 0.01 43.63 DYSLIPIDAEMIA | 12 0.12 43.75 DYSPEPSIA | 7 0.07 43.82 DYSPNOEA | 1 0.01 43.83 DYSTHYMIC DISORDER | 1 0.01 43.84 DYSTONIA | 1 0.01 43.85 DYSURIA | 3 0.03 43.88 EAR DISORDER | 1 0.01 43.89 EAR INFECTION | 1 0.01 43.90 ECZEMA | 4 0.04 43.94 ELECTROCARDIOGRAM ST SEGMENT DEPRESSION | 1 0.01 43.95 ELECTROCARDIOGRAM ST SEGMENT ELEVATION | 1 0.01 43.96 ELECTROLYTE SUBSTITUTION THERAPY | 1 0.01 43.97 EMBOLISM | 1 0.01 43.98 EMPHYSEMA | 5 0.05 44.03 ENCEPHALITIS HERPES | 1 0.01 44.04 ENCEPHALOPATHY | 3 0.03 44.07 ENDOCRINE DISORDER | 1 0.01 44.08 ENDOMETRIAL CANCER | 1 0.01 44.09 ENDOMETRIAL CANCER RECURRENT | 1 0.01 44.10 ENDOMETRIAL HYPERPLASIA | 1 0.01 44.11 ENDOMETRIOSIS | 4 0.04 44.15 ENTERAL NUTRITION | 1 0.01 44.16 ENTERITIS | 1 0.01 44.17 EPIDURAL ANAESTHESIA | 2 0.02 44.19 EPILEPSY | 48 0.48 44.67 ERECTILE DYSFUNCTION | 18 0.18 44.85 ERYSIPELAS | 2 0.02 44.87 ERYTHROSIS | 1 0.01 44.88 ESSENTIAL HYPERTENSION | 28 0.28 45.16 ESSENTIAL TREMOR | 1 0.01 45.17 EX-SMOKER | 25 0.25 45.42 EXTRAPYRAMIDAL DISORDER | 2 0.02 45.44 EYE DISCHARGE | 1 0.01 45.45 EYE INFECTION | 1 0.01 45.46 FABRY'S DISEASE | 1 0.01 45.47 FACIAL PAIN | 2 0.02 45.49 FACTOR IX DEFICIENCY | 3 0.03 45.52 FACTOR VIII DEFICIENCY | 4 0.04 45.56 FATIGUE | 2 0.02 45.58 FEBRILE NEUTROPENIA | 1 0.01 45.59 FEELING OF RELAXATION | 1 0.01 45.60 FIBROMYALGIA | 9 0.09 45.69 FLANK PAIN | 2 0.02 45.71 FLATULENCE | 2 0.02 45.73 FLUID REPLACEMENT | 9 0.09 45.82 FLUID RETENTION | 2 0.02 45.84 FRACTURE | 2 0.02 45.86 FUNGAL INFECTION | 11 0.11 45.97 GAMMOPATHY | 1 0.01 45.98 GASTRIC CANCER | 10 0.10 46.08 GASTRIC DISORDER | 8 0.08 46.16 GASTRIC ULCER | 20 0.20 46.36 GASTRITIS | 27 0.27 46.63 GASTRITIS PROPHYLAXIS | 8 0.08 46.71 GASTROENTERITIS | 1 0.01 46.72 GASTROENTERITIS CRYPTOSPORIDIAL | 3 0.03 46.75 GASTROINTESTINAL DISORDER | 3 0.03 46.78 GASTROINTESTINAL DISORDER THERAPY | 1 0.01 46.79 GASTROINTESTINAL MOTILITY DISORDER | 1 0.01 46.80 GASTROINTESTINAL OBSTRUCTION | 1 0.01 46.81 GASTROINTESTINAL STROMAL TUMOUR | 15 0.15 46.96 GASTROOESOPHAGEAL REFLUX DISEASE | 28 0.28 47.24 GASTROOESOPHAGEAL SPHINCTER INSUFFICI.. | 1 0.01 47.25 GAUCHER'S DISEASE | 5 0.05 47.30 GENERAL ANAESTHESIA | 23 0.23 47.53 GENERAL PHYSICAL CONDITION | 2 0.02 47.55 GENERAL PHYSICAL HEALTH DETERIORATION | 3 0.03 47.58 GENERALISED ANXIETY DISORDER | 5 0.05 47.63 GERM CELL CANCER | 4 0.04 47.67 GLAUCOMA | 27 0.27 47.94 GLIOBLASTOMA | 3 0.03 47.97 GLIOBLASTOMA MULTIFORME | 10 0.10 48.07 GLIOMA | 6 0.06 48.13 GLIOSARCOMA | 1 0.01 48.14 GLOMERULONEPHRITIS PROLIFERATIVE | 2 0.02 48.16 GLUCOSE TOLERANCE IMPAIRED | 1 0.01 48.17 GLYCOGEN STORAGE DISEASE TYPE II | 7 0.07 48.24 GOITRE | 1 0.01 48.25 GOUT | 6 0.06 48.31 GRAFT VERSUS HOST DISEASE | 3 0.03 48.34 GRAND MAL CONVULSION | 3 0.03 48.37 GRANULOMA ANNULARE | 1 0.01 48.38 GROWTH HORMONE DEFICIENCY | 11 0.11 48.49 GROWTH RETARDATION | 1 0.01 48.50 GUILLAIN-BARRE SYNDROME | 3 0.03 48.53 HAEMOCHROMATOSIS | 1 0.01 48.54 HAEMORRHAGE | 4 0.04 48.58 HAEMORRHOIDS | 1 0.01 48.59 HAEMOSIDEROSIS | 1 0.01 48.60 HAEMOSTASIS | 1 0.01 48.61 HALLUCINATION | 1 0.01 48.62 HALLUCINATION, AUDITORY | 1 0.01 48.63 HALLUCINATION, VISUAL | 1 0.01 48.64 HEADACHE | 14 0.14 48.78 HEART AND LUNG TRANSPLANT | 2 0.02 48.80 HEART RATE | 1 0.01 48.81 HEART RATE ABNORMAL | 1 0.01 48.82 HEART TRANSPLANT | 5 0.05 48.87 HELICOBACTER GASTRITIS | 1 0.01 48.88 HELICOBACTER INFECTION | 3 0.03 48.91 HELICOBACTER PYLORI IDENTIFICATION TE.. | 1 0.01 48.92 HEMIPLEGIA | 1 0.01 48.93 HEPATIC CIRRHOSIS | 5 0.05 48.98 HEPATIC ENCEPHALOPATHY | 1 0.01 48.99 HEPATIC FUNCTION ABNORMAL | 2 0.02 49.01 HEPATIC MASS | 1 0.01 49.02 HEPATIC NEOPLASM MALIGNANT | 10 0.10 49.12 HEPATIC STEATOSIS | 2 0.02 49.14 HEPATIC VEIN STENOSIS | 1 0.01 49.15 HEPATITIS | 2 0.02 49.17 HEPATITIS B | 14 0.14 49.31 HEPATITIS B DNA ASSAY | 1 0.01 49.32 HEPATITIS B VIRUS | 1 0.01 49.33 HEPATITIS C | 63 0.63 49.96 HEREDITARY HAEMOCHROMATOSIS | 1 0.01 49.97 HERNIA | 4 0.04 50.01 HERPES SIMPLEX | 2 0.02 50.03 HERPES VIRUS INFECTION | 2 0.02 50.05 HERPES ZOSTER | 18 0.18 50.23 HIATUS HERNIA | 3 0.03 50.26 HICCUPS | 2 0.02 50.28 HIGH DENSITY LIPOPROTEIN DECREASED | 1 0.01 50.29 HISTIOCYTOSIS HAEMATOPHAGIC | 1 0.01 50.30 HISTOPLASMOSIS | 1 0.01 50.31 HIV INFECTION | 244 2.44 52.75 HIV TEST POSITIVE | 1 0.01 52.76 HORMONE LEVEL ABNORMAL | 1 0.01 52.77 HORMONE REPLACEMENT THERAPY | 44 0.44 53.21 HORMONE THERAPY | 1 0.01 53.22 HOT FLUSH | 1 0.01 53.23 HUMAN IMMUNODEFICIENCY VIRUS TRANSMIS.. | 2 0.02 53.25 HYPERCALCAEMIA | 1 0.01 53.26 HYPERCHOLESTEROLAEMIA | 68 0.68 53.94 HYPERGLYCAEMIA | 3 0.03 53.97 HYPERKALAEMIA | 1 0.01 53.98 HYPERLIPIDAEMIA | 43 0.43 54.41 HYPERPARATHYROIDISM | 2 0.02 54.43 HYPERPARATHYROIDISM SECONDARY | 8 0.08 54.51 HYPERPHOSPHATAEMIA | 5 0.05 54.56 HYPERPROLACTINAEMIA | 1 0.01 54.57 HYPERSENSITIVITY | 15 0.15 54.72 HYPERTENSION | 427 4.27 58.99 HYPERTENSIVE HEART DISEASE | 2 0.02 59.01 HYPERTHYROIDISM | 2 0.02 59.03 HYPERTONIA | 5 0.05 59.08 HYPERTONIC BLADDER | 9 0.09 59.17 HYPERTRIGLYCERIDAEMIA | 1 0.01 59.18 HYPERURICAEMIA | 11 0.11 59.29 HYPOALBUMINAEMIA | 1 0.01 59.30 HYPOKALAEMIA | 8 0.08 59.38 HYPONATRAEMIA | 2 0.02 59.40 HYPOPHARYNGEAL CANCER | 3 0.03 59.43 HYPOPHARYNGEAL CANCER STAGE IV | 3 0.03 59.46 HYPOPITUITARISM | 6 0.06 59.52 HYPOTHYROIDISM | 41 0.41 59.93 HYPOTONIA | 1 0.01 59.94 HYPOVOLAEMIA | 1 0.01 59.95 HYPOXIA | 1 0.01 59.96 IDIOPATHIC PULMONARY FIBROSIS | 1 0.01 59.97 ILL-DEFINED DISORDER | 38 0.38 60.35 IMMUNODEFICIENCY | 1 0.01 60.36 IMMUNODEFICIENCY COMMON VARIABLE | 1 0.01 60.37 IMMUNOSUPPRESSANT DRUG THERAPY | 3 0.03 60.40 IMMUNOSUPPRESSION | 5 0.05 60.45 IMPAIRED GASTRIC EMPTYING | 2 0.02 60.47 IMPULSE-CONTROL DISORDER | 1 0.01 60.48 IN-STENT CORONARY ARTERY RESTENOSIS | 4 0.04 60.52 INCONTINENCE | 1 0.01 60.53 INCREASED APPETITE | 1 0.01 60.54 INDUCTION OF ANAESTHESIA | 20 0.20 60.74 INFECTION | 17 0.17 60.91 INFECTION PARASITIC | 1 0.01 60.92 INFECTION PROPHYLAXIS | 7 0.07 60.99 INFECTIVE EXACERBATION OF CHRONIC OBS.. | 2 0.02 61.01 INFLAMMATION | 5 0.05 61.06 INFLAMMATORY BOWEL DISEASE | 8 0.08 61.14 INFLAMMATORY CARCINOMA OF THE BREAST | 3 0.03 61.17 INFLUENZA | 9 0.09 61.26 INFLUENZA IMMUNISATION | 1 0.01 61.27 INFLUENZA LIKE ILLNESS | 1 0.01 61.28 INSOMNIA | 53 0.53 61.81 INSULIN-REQUIRING TYPE II DIABETES ME.. | 12 0.12 61.93 INTENTIONAL OVERDOSE | 3 0.03 61.96 INTERCOSTAL NEURALGIA | 2 0.02 61.98 INTERMITTENT CLAUDICATION | 1 0.01 61.99 INTERSTITIAL LUNG DISEASE | 3 0.03 62.02 INTERVERTEBRAL DISC DEGENERATION | 1 0.01 62.03 INTERVERTEBRAL DISC PROTRUSION | 1 0.01 62.04 INTESTINAL FUNCTIONAL DISORDER | 1 0.01 62.05 INTRAOCULAR PRESSURE INCREASED | 2 0.02 62.07 INTRAOCULAR PRESSURE TEST | 1 0.01 62.08 IRON DEFICIENCY ANAEMIA | 5 0.05 62.13 IRON OVERLOAD | 9 0.09 62.22 IRRITABILITY | 2 0.02 62.24 IRRITABLE BOWEL SYNDROME | 33 0.33 62.57 ISCHAEMIC CARDIOMYOPATHY | 1 0.01 62.58 JUVENILE ARTHRITIS | 10 0.10 62.68 KAPOSI'S SARCOMA | 2 0.02 62.70 KAWASAKI'S DISEASE | 2 0.02 62.72 KERATITIS HERPETIC | 1 0.01 62.73 KERATOCONJUNCTIVITIS SICCA | 1 0.01 62.74 LABOUR INDUCTION | 1 0.01 62.75 LABYRINTHITIS | 1 0.01 62.76 LACRIMATION INCREASED | 3 0.03 62.79 LACTIC ACIDOSIS | 2 0.02 62.81 LACUNAR INFARCTION | 2 0.02 62.83 LARGE INTESTINE CARCINOMA | 5 0.05 62.88 LARYNGEAL CANCER | 5 0.05 62.93 LATENT TUBERCULOSIS | 1 0.01 62.94 LEFT VENTRICULAR DYSFUNCTION | 1 0.01 62.95 LEIOMYOSARCOMA | 2 0.02 62.97 LENNOX-GASTAUT SYNDROME | 1 0.01 62.98 LEUKAEMIA | 1 0.01 62.99 LEUKOPENIA | 1 0.01 63.00 LICHEN SCLEROSUS | 2 0.02 63.02 LIP SWELLING | 1 0.01 63.03 LIPID METABOLISM DISORDER | 1 0.01 63.04 LIPIDS INCREASED | 2 0.02 63.06 LIVER DISORDER | 1 0.01 63.07 LIVER TRANSPLANT | 10 0.10 63.17 LOW DENSITY LIPOPROTEIN INCREASED | 1 0.01 63.18 LOWER RESPIRATORY TRACT INFECTION | 11 0.11 63.29 LUNG ADENOCARCINOMA | 3 0.03 63.32 LUNG ADENOCARCINOMA METASTATIC | 1 0.01 63.33 LUNG ADENOCARCINOMA STAGE IV | 1 0.01 63.34 LUNG CANCER METASTATIC | 3 0.03 63.37 LUNG CARCINOMA CELL TYPE UNSPECIFIED .. | 1 0.01 63.38 LUNG DISORDER | 1 0.01 63.39 LUNG INFECTION | 4 0.04 63.43 LUNG NEOPLASM MALIGNANT | 9 0.09 63.52 LUNG SQUAMOUS CELL CARCINOMA STAGE IV | 1 0.01 63.53 LUNG SQUAMOUS CELL CARCINOMA STAGE UN.. | 2 0.02 63.55 LUNG TRANSPLANT | 5 0.05 63.60 LUTEAL PHASE DEFICIENCY | 2 0.02 63.62 LYME DISEASE | 1 0.01 63.63 LYMPH NODE TUBERCULOSIS | 1 0.01 63.64 LYMPHADENOPATHY | 1 0.01 63.65 LYMPHOMA | 15 0.15 63.80 MACULAR DEGENERATION | 15 0.15 63.95 MAINTENANCE OF ANAESTHESIA | 11 0.11 64.06 MAJOR DEPRESSION | 12 0.12 64.18 MALAISE | 1 0.01 64.19 MALARIA | 1 0.01 64.20 MALARIA PROPHYLAXIS | 6 0.06 64.26 MALE PATTERN BALDNESS | 3 0.03 64.29 MALIGNANT MEDIASTINAL NEOPLASM | 4 0.04 64.33 MALIGNANT MELANOMA | 7 0.07 64.40 MANIA | 3 0.03 64.43 MANTLE CELL LYMPHOMA | 7 0.07 64.50 MEDICAL DIET | 9 0.09 64.59 MEDICATION ERROR | 4 0.04 64.63 MEDULLARY THYROID CANCER | 3 0.03 64.66 MEGACOLON | 1 0.01 64.67 MEMORY IMPAIRMENT | 1 0.01 64.68 MENINGIOMA | 1 0.01 64.69 MENINGITIS | 1 0.01 64.70 MENINGITIS PNEUMOCOCCAL | 5 0.05 64.75 MENINGOENCEPHALITIS HERPETIC | 2 0.02 64.77 MENOPAUSAL SYMPTOMS | 12 0.12 64.89 MENOPAUSE | 16 0.16 65.05 MENORRHAGIA | 4 0.04 65.09 MENSTRUATION IRREGULAR | 4 0.04 65.13 MENTAL DISORDER | 6 0.06 65.19 METASTASES TO BONE | 38 0.38 65.57 METASTASES TO CENTRAL NERVOUS SYSTEM | 9 0.09 65.66 METASTASES TO MENINGES | 1 0.01 65.67 METASTASIS | 2 0.02 65.69 METASTATIC MALIGNANT MELANOMA | 5 0.05 65.74 METASTATIC NEOPLASM | 2 0.02 65.76 METASTATIC RENAL CELL CARCINOMA | 28 0.28 66.04 METRORRHAGIA | 1 0.01 66.05 MICTURITION DISORDER | 1 0.01 66.06 MICTURITION URGENCY | 1 0.01 66.07 MIGRAINE | 12 0.12 66.19 MIGRAINE PROPHYLAXIS | 2 0.02 66.21 MINERAL SUPPLEMENTATION | 3 0.03 66.24 MITRAL VALVE DISEASE | 1 0.01 66.25 MITRAL VALVE INCOMPETENCE | 1 0.01 66.26 MITRAL VALVE PROLAPSE | 1 0.01 66.27 MITRAL VALVE REPLACEMENT | 3 0.03 66.30 MUCOSAL INFLAMMATION | 2 0.02 66.32 MULTIPLE ALLERGIES | 10 0.10 66.42 MULTIPLE MYELOMA | 92 0.92 67.34 MULTIPLE SCLEROSIS | 157 1.57 68.91 MULTIPLE SCLEROSIS RELAPSE | 2 0.02 68.93 MUSCLE HAEMORRHAGE | 1 0.01 68.94 MUSCLE RELAXANT THERAPY | 4 0.04 68.98 MUSCLE SPASMS | 5 0.05 69.03 MUSCLE SPASTICITY | 15 0.15 69.18 MUSCULOSKELETAL CHEST PAIN | 3 0.03 69.21 MUSCULOSKELETAL DISCOMFORT | 2 0.02 69.23 MUSCULOSKELETAL PAIN | 6 0.06 69.29 MUSCULOSKELETAL STIFFNESS | 2 0.02 69.31 MYALGIA | 4 0.04 69.35 MYASTHENIA GRAVIS | 6 0.06 69.41 MYCOBACTERIA TEST | 4 0.04 69.45 MYCOBACTERIAL INFECTION | 4 0.04 69.49 MYCOBACTERIUM AVIUM COMPLEX INFECTION | 3 0.03 69.52 MYELODYSPLASTIC SYNDROME | 20 0.20 69.72 MYELOFIBROSIS | 4 0.04 69.76 MYELOID LEUKAEMIA | 1 0.01 69.77 MYOCARDIAL INFARCTION | 7 0.07 69.84 MYOCARDIAL ISCHAEMIA | 2 0.02 69.86 NAIL TINEA | 4 0.04 69.90 NASAL CONGESTION | 2 0.02 69.92 NASAL MUCOSAL DISORDER | 1 0.01 69.93 NASOPHARYNGEAL CANCER | 3 0.03 69.96 NASOPHARYNGITIS | 12 0.12 70.08 NAUSEA | 30 0.30 70.38 NECK PAIN | 5 0.05 70.43 NECROTISING FASCIITIS | 1 0.01 70.44 NEOPLASM | 1 0.01 70.45 NEOPLASM MALIGNANT | 11 0.11 70.56 NEPHROGENIC ANAEMIA | 1 0.01 70.57 NEPHROTIC SYNDROME | 13 0.13 70.70 NERVE INJURY | 3 0.03 70.73 NERVOUS SYSTEM DISORDER | 1 0.01 70.74 NERVOUSNESS | 2 0.02 70.76 NEURALGIA | 24 0.24 71.00 NEUROBLASTOMA | 6 0.06 71.06 NEURODEGENERATIVE DISORDER | 1 0.01 71.07 NEUROENDOCRINE TUMOUR | 1 0.01 71.08 NEUROGENIC BLADDER | 3 0.03 71.11 NEUROMUSCULAR BLOCKADE REVERSAL | 4 0.04 71.15 NEUROMYELITIS OPTICA | 1 0.01 71.16 NEUROPATHY | 6 0.06 71.22 NEUROPATHY PERIPHERAL | 2 0.02 71.24 NEUROSIS | 4 0.04 71.28 NEUTROPENIA | 1 0.01 71.29 NEUTROPHIL COUNT DECREASED | 1 0.01 71.30 NICOTINE DEPENDENCE | 2 0.02 71.32 NIGHT SWEATS | 1 0.01 71.33 NIGHTMARE | 1 0.01 71.34 NOCTURIA | 1 0.01 71.35 NON-HODGKIN'S LYMPHOMA | 43 0.43 71.78 NON-HODGKIN'S LYMPHOMA STAGE I | 1 0.01 71.79 NON-HODGKIN'S LYMPHOMA STAGE IV | 9 0.09 71.88 NON-SMALL CELL LUNG CANCER | 106 1.06 72.94 NON-SMALL CELL LUNG CANCER METASTATIC | 6 0.06 73.00 NON-SMALL CELL LUNG CANCER STAGE IV | 1 0.01 73.01 NOSOCOMIAL INFECTION | 1 0.01 73.02 NUCLEAR MAGNETIC RESONANCE IMAGING | 3 0.03 73.05 NUCLEAR MAGNETIC RESONANCE IMAGING BR.. | 1 0.01 73.06 NUTRITIONAL SUPPORT | 7 0.07 73.13 OBESITY | 7 0.07 73.20 OBSESSIVE-COMPULSIVE DISORDER | 2 0.02 73.22 OBSESSIVE-COMPULSIVE PERSONALITY DISO.. | 1 0.01 73.23 OEDEMA | 10 0.10 73.33 OEDEMA DUE TO HEPATIC DISEASE | 1 0.01 73.34 OESOPHAGEAL CANDIDIASIS | 3 0.03 73.37 OESOPHAGEAL CARCINOMA | 1 0.01 73.38 OESOPHAGEAL OEDEMA | 1 0.01 73.39 OESOPHAGITIS | 1 0.01 73.40 OESTRADIOL DECREASED | 2 0.02 73.42 OESTROGEN REPLACEMENT THERAPY | 3 0.03 73.45 OFF LABEL USE | 3 0.03 73.48 OLIGODENDROGLIOMA | 2 0.02 73.50 OLIGOMENORRHOEA | 1 0.01 73.51 ONYCHOMYCOSIS | 1 0.01 73.52 OPEN ANGLE GLAUCOMA | 1 0.01 73.53 OPPORTUNISTIC INFECTION PROPHYLAXIS | 1 0.01 73.54 ORAL CANDIDIASIS | 4 0.04 73.58 ORAL CONTRACEPTION | 7 0.07 73.65 ORAL PAIN | 1 0.01 73.66 ORTHOSTATIC HYPOTENSION | 1 0.01 73.67 OSTEITIS DEFORMANS | 3 0.03 73.70 OSTEOARTHRITIS | 12 0.12 73.82 OSTEOLYSIS | 2 0.02 73.84 OSTEOMYELITIS | 1 0.01 73.85 OSTEOPENIA | 15 0.15 74.00 OSTEOPOROSIS | 218 2.18 76.18 OSTEOPOROSIS POSTMENOPAUSAL | 10 0.10 76.28 OSTEOPOROSIS PROPHYLAXIS | 4 0.04 76.32 OSTEOPOROTIC FRACTURE | 3 0.03 76.35 OVARIAN CANCER | 17 0.17 76.52 OVARIAN CANCER METASTATIC | 1 0.01 76.53 OVARIAN CANCER RECURRENT | 2 0.02 76.55 OVARIAN HAEMORRHAGE | 1 0.01 76.56 OVERWEIGHT | 1 0.01 76.57 OVULATION INDUCTION | 1 0.01 76.58 OXYGEN SATURATION DECREASED | 1 0.01 76.59 PAIN | 177 1.77 78.36 PAIN IN EXTREMITY | 9 0.09 78.45 PAIN MANAGEMENT | 5 0.05 78.50 PAIN PROPHYLAXIS | 1 0.01 78.51 PALLIATIVE CARE | 1 0.01 78.52 PANCREATIC CARCINOMA | 5 0.05 78.57 PANCREATIC CARCINOMA METASTATIC | 3 0.03 78.60 PANCREATIC INSUFFICIENCY | 2 0.02 78.62 PANCREATITIS | 2 0.02 78.64 PANCREATITIS ACUTE | 1 0.01 78.65 PANEL-REACTIVE ANTIBODY | 2 0.02 78.67 PANIC ATTACK | 9 0.09 78.76 PANIC DISORDER | 12 0.12 78.88 PARAESTHESIA | 2 0.02 78.90 PARALYSIS | 1 0.01 78.91 PARANOIA | 5 0.05 78.96 PARENTERAL NUTRITION | 2 0.02 78.98 PARKINSON'S DISEASE | 38 0.38 79.36 PARKINSONISM | 7 0.07 79.43 PAROPHTHALMIA | 1 0.01 79.44 PEMPHIGOID | 2 0.02 79.46 PEPTIC ULCER | 2 0.02 79.48 PEPTIC ULCER HAEMORRHAGE | 2 0.02 79.50 PERCUTANEOUS CORONARY INTERVENTION | 2 0.02 79.52 PERIOPERATIVE ANALGESIA | 1 0.01 79.53 PERIPHERAL BLOOD STEM CELL APHERESIS | 1 0.01 79.54 PERITONEAL CARCINOMA | 1 0.01 79.55 PERITONEAL DIALYSIS | 6 0.06 79.61 PERITONITIS | 5 0.05 79.66 PERSONALITY DISORDER | 1 0.01 79.67 PETIT MAL EPILEPSY | 2 0.02 79.69 PHANTOM PAIN | 1 0.01 79.70 PHARYNGITIS | 4 0.04 79.74 PHARYNGOLARYNGEAL PAIN | 12 0.12 79.86 PHLEBITIS | 3 0.03 79.89 PLASMACYTOMA | 1 0.01 79.90 PLASTIC SURGERY | 1 0.01 79.91 PLEURAL MESOTHELIOMA | 4 0.04 79.95 PNEUMOCYSTIS JIROVECI PNEUMONIA | 7 0.07 80.02 PNEUMONIA | 26 0.26 80.28 PNEUMONIA ASPIRATION | 3 0.03 80.31 POLLAKIURIA | 2 0.02 80.33 POLYARTHRITIS | 11 0.11 80.44 POLYCYTHAEMIA | 1 0.01 80.45 POLYCYTHAEMIA VERA | 1 0.01 80.46 POLYMYALGIA RHEUMATICA | 2 0.02 80.48 POLYMYOSITIS | 2 0.02 80.50 POLYNEUROPATHY | 2 0.02 80.52 POLYURIA | 2 0.02 80.54 POOR PERIPHERAL CIRCULATION | 1 0.01 80.55 POST HERPETIC NEURALGIA | 2 0.02 80.57 POST PROCEDURAL HAEMORRHAGE | 1 0.01 80.58 POST-TRAUMATIC STRESS DISORDER | 5 0.05 80.63 POSTOPERATIVE ANALGESIA | 2 0.02 80.65 POSTOPERATIVE CARE | 3 0.03 80.68 POUCHITIS | 3 0.03 80.71 PRE-EXISTING DISEASE | 1 0.01 80.72 PREMATURE MENOPAUSE | 1 0.01 80.73 PREMEDICATION | 37 0.37 81.10 PREMENSTRUAL SYNDROME | 1 0.01 81.11 PRENATAL CARE | 2 0.02 81.13 PREOPERATIVE CARE | 1 0.01 81.14 PREVENTIVE SURGERY | 2 0.02 81.16 PROCEDURAL PAIN | 11 0.11 81.27 PROCTITIS ULCERATIVE | 2 0.02 81.29 PROCTOCOLITIS | 4 0.04 81.33 PRODUCTIVE COUGH | 2 0.02 81.35 PROGESTERONE DECREASED | 1 0.01 81.36 PROLACTINOMA | 1 0.01 81.37 PROPHYLAXIS | 113 1.13 82.50 PROPHYLAXIS AGAINST DIARRHOEA | 1 0.01 82.51 PROPHYLAXIS AGAINST GASTROINTESTINAL .. | 11 0.11 82.62 PROPHYLAXIS AGAINST GRAFT VERSUS HOST.. | 5 0.05 82.67 PROPHYLAXIS AGAINST HIV INFECTION | 5 0.05 82.72 PROPHYLAXIS AGAINST TRANSPLANT REJECT.. | 32 0.32 83.04 PROPHYLAXIS OF ABORTION | 1 0.01 83.05 PROPHYLAXIS OF NAUSEA AND VOMITING | 11 0.11 83.16 PROSTATE CANCER | 18 0.18 83.34 PROSTATE CANCER METASTATIC | 3 0.03 83.37 PROSTATE EXAMINATION ABNORMAL | 3 0.03 83.40 PROSTATIC DISORDER | 1 0.01 83.41 PROSTATIC SPECIFIC ANTIGEN INCREASED | 1 0.01 83.42 PROSTATITIS | 4 0.04 83.46 PROTEUS INFECTION | 1 0.01 83.47 PRURIGO | 2 0.02 83.49 PRURITUS | 8 0.08 83.57 PSORIASIS | 63 0.63 84.20 PSORIATIC ARTHROPATHY | 32 0.32 84.52 PSYCHOMOTOR SEIZURES | 1 0.01 84.53 PSYCHOTIC DISORDER | 21 0.21 84.74 PULMONARY CONGESTION | 1 0.01 84.75 PULMONARY EMBOLISM | 2 0.02 84.77 PULMONARY FIBROSIS | 1 0.01 84.78 PULMONARY HYPERTENSION | 16 0.16 84.94 PULMONARY MYCOSIS | 4 0.04 84.98 PULMONARY SARCOIDOSIS | 1 0.01 84.99 PULMONARY TUBERCULOSIS | 17 0.17 85.16 PYELONEPHRITIS | 2 0.02 85.18 PYOMYOSITIS | 1 0.01 85.19 PYREXIA | 28 0.28 85.47 RABIES | 15 0.15 85.62 RADICULAR PAIN | 1 0.01 85.63 RADICULOPATHY | 2 0.02 85.65 RADIOTHERAPY | 2 0.02 85.67 RASH | 8 0.08 85.75 RECTAL CANCER | 4 0.04 85.79 REFLUX GASTRITIS | 2 0.02 85.81 REFLUX OESOPHAGITIS | 11 0.11 85.92 REFRACTORY ANAEMIA | 1 0.01 85.93 RELAPSING-REMITTING MULTIPLE SCLEROSIS | 25 0.25 86.18 RENAL CANCER METASTATIC | 1 0.01 86.19 RENAL CELL CARCINOMA STAGE IV | 1 0.01 86.20 RENAL CELL CARCINOMA STAGE UNSPECIFIED | 48 0.48 86.68 RENAL DISORDER | 2 0.02 86.70 RENAL FAILURE | 5 0.05 86.75 RENAL FAILURE CHRONIC | 27 0.27 87.02 RENAL TRANSPLANT | 61 0.61 87.63 RESPIRATORY TRACT CONGESTION | 1 0.01 87.64 RESPIRATORY TRACT INFECTION | 6 0.06 87.70 RESTLESS LEGS SYNDROME | 8 0.08 87.78 RESTLESSNESS | 2 0.02 87.80 RETINITIS | 1 0.01 87.81 RETINOBLASTOMA | 5 0.05 87.86 RHABDOMYOSARCOMA | 10 0.10 87.96 RHEUMATOID ARTHRITIS | 352 3.52 91.48 RHINITIS ALLERGIC | 6 0.06 91.54 RIB FRACTURE | 2 0.02 91.56 ROSACEA | 5 0.05 91.61 ROUTINE HEALTH MAINTENANCE | 2 0.02 91.63 SALIVARY GLAND CANCER STAGE IV | 1 0.01 91.64 SALIVARY HYPERSECRETION | 2 0.02 91.66 SARCOMA | 2 0.02 91.68 SARCOMA UTERUS | 1 0.01 91.69 SCEDOSPORIUM INFECTION | 1 0.01 91.70 SCHIZOAFFECTIVE DISORDER | 15 0.15 91.85 SCHIZOPHRENIA | 72 0.72 92.57 SCHIZOPHRENIA, PARANOID TYPE | 7 0.07 92.64 SCHIZOPHRENIA, RESIDUAL TYPE | 4 0.04 92.68 SCIATIC NERVE NEUROPATHY | 1 0.01 92.69 SCIATICA | 9 0.09 92.78 SCOLIOSIS | 1 0.01 92.79 SEASONAL ALLERGY | 9 0.09 92.88 SECONDARY HYPOGONADISM | 1 0.01 92.89 SECONDARY PROGRESSIVE MULTIPLE SCLERO.. | 9 0.09 92.98 SECRETION DISCHARGE | 1 0.01 92.99 SEDATION | 4 0.04 93.03 SEDATIVE THERAPY | 5 0.05 93.08 SENSORY LOSS | 1 0.01 93.09 SEPSIS | 8 0.08 93.17 SEPTIC SHOCK | 4 0.04 93.21 SERONEGATIVE ARTHRITIS | 2 0.02 93.23 SHOCK | 2 0.02 93.25 SICK SINUS SYNDROME | 2 0.02 93.27 SICKLE CELL ANAEMIA | 1 0.01 93.28 SINUS DISORDER | 4 0.04 93.32 SINUSITIS | 16 0.16 93.48 SJOGREN'S SYNDROME | 2 0.02 93.50 SKIN TOXICITY | 2 0.02 93.52 SKIN WRINKLING | 4 0.04 93.56 SLEEP DISORDER | 31 0.31 93.87 SMALL CELL LUNG CANCER STAGE UNSPECIF.. | 7 0.07 93.94 SMOKING CESSATION THERAPY | 71 0.71 94.65 SNEEZING | 2 0.02 94.67 SOCIAL PHOBIA | 2 0.02 94.69 SOMATOFORM DISORDER | 1 0.01 94.70 SPINA BIFIDA | 1 0.01 94.71 SPINAL COLUMN STENOSIS | 4 0.04 94.75 SPINAL FUSION SURGERY | 2 0.02 94.77 SPINAL OSTEOARTHRITIS | 2 0.02 94.79 SPONDYLITIS | 5 0.05 94.84 SPONDYLOARTHROPATHY | 5 0.05 94.89 SPUTUM RETENTION | 6 0.06 94.95 SQUAMOUS CELL CARCINOMA | 36 0.36 95.31 STAPHYLOCOCCAL ABSCESS | 1 0.01 95.32 STAPHYLOCOCCAL INFECTION | 3 0.03 95.35 STEM CELL TRANSPLANT | 16 0.16 95.51 STENT PLACEMENT | 7 0.07 95.58 STOMACH DISCOMFORT | 1 0.01 95.59 STOMATITIS | 1 0.01 95.60 STRABISMUS | 1 0.01 95.61 STREPTOCOCCAL INFECTION | 1 0.01 95.62 STRESS | 1 0.01 95.63 STRESS ULCER | 1 0.01 95.64 SUBSTANCE ABUSE | 1 0.01 95.65 SUDDEN HEARING LOSS | 1 0.01 95.66 SUICIDE ATTEMPT | 3 0.03 95.69 SUPPLEMENTATION THERAPY | 9 0.09 95.78 SURGERY | 1 0.01 95.79 SWELLING | 3 0.03 95.82 SWOLLEN TONGUE | 1 0.01 95.83 SYSTEMIC ANTIBACTERIAL THERAPY | 1 0.01 95.84 SYSTEMIC ANTIVIRAL TREATMENT | 4 0.04 95.88 SYSTEMIC CANDIDA | 1 0.01 95.89 SYSTEMIC LUPUS ERYTHEMATOSUS | 13 0.13 96.02 SYSTEMIC SCLEROSIS | 1 0.01 96.03 T-CELL LYMPHOMA | 1 0.01 96.04 T-CELL TYPE ACUTE LEUKAEMIA | 12 0.12 96.16 TACHYCARDIA | 4 0.04 96.20 TEMPORAL ARTERITIS | 2 0.02 96.22 TEMPORAL LOBE EPILEPSY | 1 0.01 96.23 TESTICULAR CANCER METASTATIC | 5 0.05 96.28 TESTICULAR NEOPLASM | 3 0.03 96.31 TESTIS CANCER | 3 0.03 96.34 THALASSAEMIA | 1 0.01 96.35 THALASSAEMIA BETA | 1 0.01 96.36 THROAT CANCER | 1 0.01 96.37 THROMBOLYSIS | 3 0.03 96.40 THROMBOPHLEBITIS | 1 0.01 96.41 THROMBOSIS | 3 0.03 96.44 THROMBOSIS PROPHYLAXIS | 14 0.14 96.58 THROMBOTIC MICROANGIOPATHY | 2 0.02 96.60 THROMBOTIC THROMBOCYTOPENIC PURPURA | 2 0.02 96.62 THYROID DISORDER | 16 0.16 96.78 THYROIDECTOMY | 1 0.01 96.79 TIC | 1 0.01 96.80 TINEA INFECTION | 1 0.01 96.81 TINEA PEDIS | 2 0.02 96.83 TOBACCO ABUSE | 3 0.03 96.86 TOBACCO USER | 3 0.03 96.89 TONGUE DISORDER | 1 0.01 96.90 TONGUE NEOPLASM MALIGNANT STAGE UNSPE.. | 1 0.01 96.91 TONSIL CANCER | 1 0.01 96.92 TONSILLITIS | 1 0.01 96.93 TOOTH ABSCESS | 1 0.01 96.94 TOOTH EXTRACTION | 1 0.01 96.95 TOOTH INFECTION | 1 0.01 96.96 TOOTHACHE | 6 0.06 97.02 TOXOPLASMOSIS | 1 0.01 97.03 TOXOPLASMOSIS PROPHYLAXIS | 1 0.01 97.04 TRANSFUSION | 1 0.01 97.05 TREMOR | 2 0.02 97.07 TRICHOPHYTOSIS | 1 0.01 97.08 TRIGEMINAL NEURALGIA | 2 0.02 97.10 TUBERCULOSIS | 9 0.09 97.19 TYPE 1 DIABETES MELLITUS | 29 0.29 97.48 TYPE 2 DIABETES MELLITUS | 113 1.13 98.61 TYPHOID FEVER | 1 0.01 98.62 ULCER | 1 0.01 98.63 UNEVALUABLE EVENT | 19 0.19 98.82 UPPER RESPIRATORY TRACT INFECTION | 1 0.01 98.83 UPPER RESPIRATORY TRACT INFLAMMATION | 6 0.06 98.89 URGE INCONTINENCE | 1 0.01 98.90 URINARY INCONTINENCE | 4 0.04 98.94 URINARY TRACT CARCINOMA IN SITU | 1 0.01 98.95 URINARY TRACT INFECTION | 24 0.24 99.19 URINE ANALYSIS ABNORMAL | 1 0.01 99.20 URTICARIA | 1 0.01 99.21 URTICARIA CHRONIC | 2 0.02 99.23 URTICARIA PRESSURE | 2 0.02 99.25 UTERINE CONTRACTIONS DURING PREGNANCY | 1 0.01 99.26 UTERINE HAEMORRHAGE | 1 0.01 99.27 UTERINE LEIOMYOMA | 1 0.01 99.28 UTERUS EVACUATION | 1 0.01 99.29 VAGINAL HAEMORRHAGE | 1 0.01 99.30 VAGINAL INFECTION | 2 0.02 99.32 VARICELLA | 1 0.01 99.33 VARICES OESOPHAGEAL | 2 0.02 99.35 VASCULAR DEMENTIA | 1 0.01 99.36 VASCULITIS | 1 0.01 99.37 VEIN DISORDER | 1 0.01 99.38 VENOUS OCCLUSION | 3 0.03 99.41 VENOUS STASIS | 1 0.01 99.42 VENTRICULAR ARRHYTHMIA | 2 0.02 99.44 VENTRICULAR FIBRILLATION | 1 0.01 99.45 VENTRICULAR TACHYCARDIA | 2 0.02 99.47 VERTIGO | 1 0.01 99.48 VIRAL INFECTION | 2 0.02 99.50 VISCERAL LEISHMANIASIS | 2 0.02 99.52 VITAMIN SUPPLEMENTATION | 13 0.13 99.65 VOCAL CORD DISORDER | 1 0.01 99.66 VOLUME BLOOD | 1 0.01 99.67 VOMITING | 6 0.06 99.73 VULVOVAGINAL MYCOTIC INFECTION | 2 0.02 99.75 WALDENSTROM'S MACROGLOBULINAEMIA | 1 0.01 99.76 WEIGHT CONTROL | 6 0.06 99.82 WEIGHT DECREASED | 1 0.01 99.83 WEIGHT INCREASED | 1 0.01 99.84 WEIGHT LOSS DIET | 3 0.03 99.87 WOUND COMPLICATION | 10 0.10 99.97 WOUND INFECTION | 1 0.01 99.98 XERODERMA | 2 0.02 100.00 ----------------------------------------+----------------------------------- Total | 10,000 100.00 by Jean Roth , jroth@nber.org , 18 Dec 2015